Proteome Sciences plc is engaged in biomarker research and development in applied proteomics, using techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It is a Protein Biomarker Discovery Service company specializing in Proteomics and Peptidomics applications and a mass spectrometry protein company. The Company�s three geographic segments include: United Kingdom, Germany and the United States. The main focus of research is to address neurological, neurodegenerative, cardiovascular and cancer conditions and blood biomarkers in stroke, brain damage, solid organ transplant rejection and Alzheimer�s disease. The company�s subsidiaries include Proteome Sciences R&D Verwaltungs GmbH, Proteome Sciences R&D GmbH & Co. KG, Xzillion GmbH & Co. KG, Proteome Sciences, Inc., Veri-Q Inc. and Phenomics Limited.